Drug
R Dxd
R Dxd: highest development phase Phase 3, developed by Merck. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| R-DXd NCT07776691 | Phase 3 | Ovarian Cancer |
| R-DXd NCT07743164 | Phase 3 | Ovarian Cancer |
Latest
No recent events.
Follow R Dxd on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.